Literature DB >> 1769692

Molecular cloning and characterization of ovine IL-1 alpha and IL-1 beta.

A E Andrews1, G J Barcham, M R Brandon, A D Nash.   

Abstract

Interleukin-1 (IL-1) is a cytokine with a wide range of effects on a variety of cell types. By hybridization with human IL-1 alpha and IL-1 beta cDNA probes, the corresponding ovine cDNAs were isolated from a stimulated alveolar macrophage cDNA library. The sequences of these cDNAs showed that ovine IL-1 alpha and IL-1 beta encode proteins of 268 and 266 amino acids, respectively, with both the nucleotide and amino acid sequences showing a high degree of homology with their human, mouse and bovine equivalents. In a mammalian COS cell-expression system these cDNAs produced biologically active IL-1. Further experiments demonstrated the importance of sequences within the 3' untranslated portion of the cDNAs in determining the level of expression of these molecules. The analysis of expression of IL-1 alpha- and IL-1 beta-specific mRNA in response to endotoxin, phorbol myristic acid (PMA) or PMA plus ionomycin revealed a distinct pattern of differential regulation of the two genes. From genomic analysis both IL-1 alpha and IL-1 beta appear to exist as single copies in the ovine genome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769692      PMCID: PMC1384639     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Porcine IL-1 alpha cDNA nucleotide sequence.

Authors:  C R Maliszewski; B R Renshaw; M A Schoenborn; J F Urban; P E Baker
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

2.  IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1.

Authors:  R Schindler; P Ghezzi; C A Dinarello
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

3.  IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor.

Authors:  H U Beuscher; C Günther; M Röllinghoff
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

4.  A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2.

Authors:  A J Gearing; C R Bird; A Bristow; S Poole; R Thorpe
Journal:  J Immunol Methods       Date:  1987-05-04       Impact factor: 2.303

5.  Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences.

Authors:  T Wilson; R Treisman
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

6.  Cysticercosis: cellular immune responses during primary and secondary infection.

Authors:  E Meeusen; G J Barcham; M D Gorrell; M D Rickard; M R Brandon
Journal:  Parasite Immunol       Date:  1990-07       Impact factor: 2.280

7.  Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.

Authors:  S Henikoff
Journal:  Gene       Date:  1984-06       Impact factor: 3.688

8.  The adjuvanticity of interleukin 1 in vivo.

Authors:  M J Staruch; D D Wood
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

9.  Cloning and expression of murine interleukin-1 cDNA in Escherichia coli.

Authors:  P T Lomedico; U Gubler; C P Hellmann; M Dukovich; J G Giri; Y C Pan; K Collier; R Semionow; A O Chua; S B Mizel
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

10.  Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1.

Authors:  P M Cameron; G A Limjuco; J Chin; L Silberstein; J A Schmidt
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  7 in total

1.  Inflammation-induced changes in the phenotype and cytokine profile of cells migrating through skin and afferent lymph.

Authors:  P J Egan; W Kimpton; H F Seow; V M Bowles; M R Brandon; A D Nash
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

Review 2.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 3.  Clinical Trials of Immunomodulation in Ischemic Stroke.

Authors:  Roland Veltkamp; Dipender Gill
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

4.  Molecular cloning, expression and characterization of the ovine IL-2R alpha chain.

Authors:  A M Verhagen; A E Andrews; M R Brandon; A D Nash
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

5.  Evolution of T-cell receptor gamma and delta constant region and other T-cell-related proteins in the human-rodent-artiodactyl triplet.

Authors:  S Ciccarese; C Lanave; C Saccone
Journal:  Genetics       Date:  1997-02       Impact factor: 4.562

6.  Solubilization of growth hormone and other recombinant proteins from Escherichia coli inclusion bodies by using a cationic surfactant.

Authors:  N K Puri; E Crivelli; M Cardamone; R Fiddes; J Bertolini; B Ninham; M R Brandon
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

Review 7.  Interleukin-1 and acute brain injury.

Authors:  Katie N Murray; Adrian R Parry-Jones; Stuart M Allan
Journal:  Front Cell Neurosci       Date:  2015-02-06       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.